InvestLog
KYTX logo

KYTX

Kyverna Therapeutics, Inc.NASDAQHealthcare
$8.87+1.14%ClosedMarket Cap: $388.4M

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2025-12-16Wells Fargo—Overweight—
2025-12-04Morgan Stanley—Overweight—
2025-10-30Wells Fargo—Overweight—
2025-10-27HC Wainwright & Co.—Buy—
2025-08-29HC Wainwright & Co.—Buy—
2025-05-27HC Wainwright & Co.—Buy—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Thu Dec 31$-3.47$12.5M5
Fri Dec 31$-3.04$16.0M5
Sun Dec 31$-3.44$53.2M3
Mon Dec 31$-3.60$174.6M1